New Delhi: The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% while led by the genomics segment with largest market share. North America is expected to dominate the global bioinformatics market during forecast period, as per the report by Markets and Markets.
In this report, the bioinformatics market is broadly segmented on the basis of sector, products and services, application, and region. Factors such as the growing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, growing application of bioinformatics, and improved collaborative ties between companies and research institutes are driving the growth of the bioinformatics market.
On the basis of sector, the bioinformatics market is categorized into medical biotechnology, academics, animal biotechnology, agricultural technology, environmental biotechnology, forensic biotechnology, and other sectors (homeland security and defense, law enforcement groups, bioweapon creation, and evolutionary biotechnology). In 2016, the medical biotechnology segment is expected to account for the largest share of the bioinformatics market. This growth can be attributed to the increasing use of bioinformatics in drug discovery and development processes for the faster development of safe and effective drugs at reduced costs. On the basis of application, the bioinformatics market has been segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, molecular phylogenetics, and other applications (glycomics, cytomics, physiomics, and interactomics).
North America is expected to account for the largest share of the bioinformatics market in 2016. Factors such as the increasing demand for bioinformatics across genomics and proteomics research, technological advancements, increasing research funding, and presence of a large number of market players and research institutes are propelling the growth of the market in North America. The APAC bioinformatics market is expected to register the highest CAGR of 22.3% in the next five years. Increasing research outsourcing to emerging countries by pharmaceutical giants for cost saving and increasing application of genomics in biotechnology and pharmaceutical research are contributing to the high growth of the APAC bioinformatics market during the forecast period.
Product launches was the most widely adopted growth strategy pursued by players in the bioinformatics market. Major players operating in the bioinformatics market include Illumina Inc. (U.S.), Agilent Technologies (U.S.), and Thermo Fisher Scientific Inc. (U.S.), and QIAGEN N.V (Netherlands). Order a copy of Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics).
On the basis of products and services, the bioinformatics market is categorized into knowledge management tools, bioinformatics platforms, and bioinformatics services. The knowledge management tools segment is expected to account for the largest market share in 2016. However, bioinformatics platforms are expected to grow at the highest CAGR during the forecast period; the growth of this segment is due to the reduction in overall time for processing data, phylogenetic analysis, and identification of sequence similarity.
Complete report on bioinformatics market spread across 184 pages, profiling 10 companies and supported with 136 tables and 47 figures is now available here.
On a related note, another research on Next-Generation Sequencing (NGS) Market Global Forecasts to 2021 says, the diagnostics application segment is expected to account for the largest share of the NGS market, by application. The research centers & academic/government institutes end user segment is to account for the largest shares, by end user. Overall market is to reach USD 10,371.1 Million by 2021 from USD 4,031.7 Million in 2016, at a CAGR of 20.8%. Companies like Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Roche Holding AG, QIAGEN N. V., BGI, Macrogen Inc., Eurofins Scientific, and Oxford Nanopore Technologies have been profiled in this 208 pages research report available here.